跳到主要內容
115學年度【申請入學】第二階段指定項目甄試招生中

115學年度【申請入學】第二階段指定項目甄試招生中

115學年度申請入學第一階段篩選結果3/31公告於大學甄選入學委員會網頁,恭喜通過第一階篩選的北醫各學系篩選之考生。第二階報名於 4/7 開放,請注意各項時限,備妥應試,北醫大歡迎你的加入!
北醫大博士生以 AI 加速新藥研發 首獲 Google 博士生獎學金

北醫大博士生以 AI 加速新藥研發 首獲 Google 博士生獎學金

臺北醫學大學醫學科技學院「癌症生物學與藥物研發博士學位學程」博士生林偉德(Tony Eight Lin),在癌症生物學與藥物研發研究所許凱程教授團隊指導下,榮獲Google 2025年博士生獎學金。展現北醫大培育跨域與雙棲人才的堅強實力。
北醫大THE2026醫學與健康領域排名 全球251–300名 全臺第二

北醫大THE2026醫學與健康領域排名 全球251–300名 全臺第二

2026 年《泰晤士高等教育》年世界大學學科排名醫學與健康領域,北醫全球排名位居 251–300 名。在臺灣並列第二,展現其在國內醫學與健康科學高等教育體系中的穩健實力與領先地位。
北醫大榮獲「2026大學品牌力」最佳學群獎

北醫大榮獲「2026大學品牌力」最佳學群獎

北醫大榮獲104人力銀行「2026 大學品牌力」最佳學群獎,醫藥衛生學群全國第二,研發與產學力居私校之首;結合 AI 與虛擬醫院臨床實作,培育具永續素養與領袖氣質的新世代醫療人才,深獲企業肯定。
賀!榮獲經濟部節能標竿金獎

賀!榮獲經濟部節能標竿金獎

臺北醫學大學推動綠色實驗室與智慧節能,整合高效空調與永續教育行動,全面提升校園能源效率,榮獲 114 年經濟部節能標竿金獎肯定,展現大學永續治理典範。
2025全球校友日 移師馬來西亞 盛大登場

2025全球校友日 移師馬來西亞 盛大登場

北醫「全球校友日」首度移師海外,11月14-15日於馬來西亞盛大舉行。來自臺灣、馬來西亞、印度、印尼及美國等全球300名校友、產官學界貴賓與師長齊聚一堂,展現北醫校友強大的全球動員力,也象徵北醫大國際化、在地連結與跨國校友情誼的全面深化。
北醫大體系61位學者 入選2025全球Top 2%頂尖科學家

北醫大體系61位學者 入選2025全球Top 2%頂尖科學家

「2025年全球Top 2%頂尖科學家名單」,臺北醫學大學暨醫療體系61位學者入選,其中31位列入終身科學影響力榜、46位登上年度榜,16位同時入選雙榜。研究涵蓋醫學、藥學、護理、公共衛生與AI醫療等領域,展現TMU卓越科研實力與國際影響力。
北醫大勇奪5項未來科技獎與吳大猷獎

北醫大勇奪5項未來科技獎與吳大猷獎

臺北醫學大學榮獲2025未來科技獎五項大獎,展現AI醫療、智慧照護與精準醫療的創新實力,私校表現最亮眼!另有吳人傑醫師與羅偉成副教授同獲「吳大猷先生紀念獎」,再添科研榮耀。
:::

 

Artificial intelligence (AI) and digital transformation can make good doctors even better, says Ray-Jade Chen, who is a professor in surgery, an established area expert in artificial intelligence in medicine and chair of Taipei Medical University’s (TMU) board of trustees. “AI can help good doctors assist even more people and improve their treatment and possible outcomes.”

 

Advances in technology have resulted in a deluge of medical data, but healthcare providers need analysis tools and protocols to turn this data into improved outcomes for patients. “We want to create value for patients, healthcare providers and society as a whole,” Chen says. “That is our main job – through education, research and clinical service,”

 

Established in 1960, TMU has 11 colleges, more than 6,000 students a year, and six affiliated hospitals, namely Taipei Medical University Hospital, Wanfang Hospital, Shuang-Ho Hospital, Hsin Kuo Min Hospital, the Taipei Cancer Center and the Taipei Neuroscience Institute.

 

In today’s modern era of big data, healthcare providers and researchers can harness the power of analytics and AI to improve patient well-being and reduce costs. With this in mind, the university established its Research Center of Artificial Intelligence in Medicine and Health in 2019. The centre pulls together talent from across its schools and affiliated hospitals, as well as industry, and its members have a wealth of experience in medical teaching, services and technology development.

 

AI can have life-saving results in diagnostics, particularly radiology, says Chen. “For example, everyone wants to have an early diagnosis of lung cancer” as this improves treatment outcomes. Cancer is one of the leading causes of death in Taiwan, with lung cancer being one of the most lethal. Radiologists have to view many scans a day, but AI could reduce this burden and the precision of the results, says Chen. However, CT chest scans, which are used to detect lung cancer, can also image many other organs, such as the spine, aorta, oesophagus and vascular system, and AI techniques could detect anomalies in these systems too. 

 

But to develop and deploy these techniques, researchers and physicians need data. The university’s Office of Data Science includes a Clinical Data Center, Health Data Analytics and Statistics Center, Institutional Research Center and Bioinformatics Center. “We have data from a variety of sources,” says Chen, from clinical data and government surveillance information through to insurance-company claims data.

 

The wealth of such a database allows TMU researchers to collaborate with industry and other institutions on projects, such as clinical trials, he says. “We can quickly collate data sets on, for example, pancreatic cancer in our hospitals.” The same is true for collaborations with pharmaceutical companies looking to investigate adverse drug reactions.

 

AI and large datasets can also play a role in patient care, he says. Studies have found that, for suitable patients, hospital-at-home care – in which patients are closely monitored remotely but able to convalesce at home – has the same or better outcomes than being in hospital. Using AI and the Internet of Things, healthcare workers can monitor patients in real-time. Importantly, says Chen, university researchers and physicians can collect such data to check that hospital-at-home care is appropriate for different treatments.

 

“AI can help us with staff shortages and we can show whether patients receive the same, or even better, care,” he says.

 

source: Times Higher Education


回到頂端